Mirador Capital Partners LP Tenaya Therapeutics, Inc. Call Options Transaction History
Mirador Capital Partners LP
- $536 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TNYA
# of Institutions
106Shares Held
48.6MCall Options Held
74.4KPut Options Held
78.4K-
Column Group LLC San Francisco, CA9.4MShares$5.64 Million12.12% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$4.04 Million0.45% of portfolio
-
Woodline Partners LP San Francisco, CA5.92MShares$3.55 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.08MShares$2.45 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$2.44 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $24.8M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...